| INTRODUCTION
Bone regeneration can be predictably achieved when a barrier membrane is applied to isolate a bony defect from the surrounding soft tissues (guided bone regeneration [GBR] principle), thus promoting the selective repopulation of the defect by osteoprogenitor cells coming for the host bone. 1, 2 Experimental studies in both animals and humans have also demonstrated the possibility to apply GBR to regenerate bone beyond the genetically determined skeletal profile (neo-osteogenesis). [3] [4] [5] [6] This can be obtained by securing a rigid hollow dome/capsule to the bone surface, which creates a secluded space that is gradually filled by bone. 3 It has been shown that the roughness of titanium surfaces can positively influence the process of osseointegration. 7, 8 Sandblasting,
Large-grit, Acid-etching (SLA) is a commonly used technique to produce moderately rough titanium surfaces that were shown to stimulate a higher bone-to-implant contact in comparison to machined and smooth surfaces. [9] [10] [11] Chemical modification of the SLA implant surfaces to increase their surface free energy and wettability (SLActive) has been introduced to further optimize their properties. It has been
shown that during early healing stages, a hydrophilic surface can further promote interactions with osteogenic cells, biological fluids and tissues, thus enhancing the process of osteogenesis. [12] [13] [14] There is also preclinical evidence that during the early stages of osseointegration, SLActive surfaces accelerate osteogenesis, increase bone-to-implant contact 15, 16 and lead to a higher removal torque 17 in comparison to SLA surfaces. A faster osseointegration of SLActive implants in comparison to SLA ones has been histologically confirmed also in humans, 18 while clinical studies recording resonance frequency analysis have shown increased stability of hydrophilic implants during early healing periods. 19 Although both SLA and SLActive surfaces have been proven successful in preclinical [20] [21] [22] and clinical studies 23, 24 and even in demanding clinical situations (such as in the presence of type IV bone, in immediate/early loading, in poorly controlled diabetic patients and in irradiated patients), [25] [26] [27] [28] [29] [30] [31] [32] [33] very little is known regarding the molecular mechanisms behind the influence of surface hydrophilicity/hydrophobicity on the bone healing process. Previous human transcriptomic data have shown that SLActive implants are associated to an upregulation of osteogenesis-and angiogenesis-related genes compared to SLA implants at 7 and 14 days of healing. 34 Furthermore, it has been suggested that micro rough hydrophilic surfaces (SLActive) are able to modulate the inflammatory response occurring during osseous healing by downregulating the transcription of proinflammatory cytokines in macrophages. [35] [36] [37] However, a significant discrepancy may exist between the transcriptome (full set of mRNAs of protein-coding genes) of a cell and the proteins that are actually produced (proteome), which ultimately determine the biochemical reactions that the cell is carrying out. Hence, proteomic analysis represents a necessary and more advanced step for our understanding on the complex cascade of events modulated by different titanium surfaces and on their influence in clinical applications.
Currently, the number of studies applying full proteomics (not just the study of single pre-determined proteins) to understand the mechanisms behind bone regeneration are still limited. Most of the available literature consists of in vitro studies, where proteomics is applied to understand the differentiation and mechanism of action of bone cells/bone cell precursors 38, 39 and bone cells treated with anti-osteoporotic medications, [40] [41] [42] or studies where the proteome of peripheral blood monocytes of patients with normal and with low bone mineral density are investigated. 43, 44 Owing to technical challenges, very few in vivo studies have applied proteomics to bone samples. 45 Previous preclinical studies utilizing bone samples from healthy or osteoporotic-like rats either performed only a qualitative analysis of sodium dodecyl sulphatepolyacrylamide gels, 46 or focused only on the identification of specific differently regulated proteins, 47 or were able to identify only a limited number of proteins. 48, 49 Even fewer studies are available on the proteomic analysis of human bone samples. Changes in bone tissue proteome were investigated in the head and femur neck of healthy and osteopenic patients undergoing hip surgery 50 and in patients with osteoarthritis. 51 Although proteomics is a promising analytical tool, within the field of dentistry, it remains still a quite unexplored technique, mainly applied to detect potential markers for periodontitis and oral cancer in the saliva, 52, 53 or to study the dental follicle cells and their differentiation into various dental tissue cells. 54 To the best of our knowledge, no study so far has applied proteomics to understand tissue/bone regeneration techniques, osseointegration or the role of implant surfaces on bone formation.
Hence, the aim of this pilot study was to qualitatively describe the proteins and related signalling pathways expressed during the early stages of new bone formation under moderately rough hydrophobic (SLA) and hydrophilic (SLActive) titanium domes for GBR in the rabbit calvaria.
| MATERIAL AND METHODS
The study protocol was approved by the Ethical Committee of the General Directorate for Agricultural Economy and Veterinary
Medicine of Athens, Greece (protocol number 589), and was carried out in accordance with EU Directive 2010/63/EU for animal experiments. The ARRIVE guidelines for reporting animal research were followed.
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Nine 6-month-old, male, New Zealand white rabbits weighing between 3 and 4.2 kg were used. A couple of weeks of acclimatization before starting the experimental surgical procedure were allowed. The animals were fed with a standard pellet diet for the whole duration of the experiment.
General anaesthesia was induced with ketamine (1.1 mL i.m.) and xylazine (1.1 mL i.m.) and then maintained with isoflurane delivered through a vaporizer as a mixture of 3% in oxygen (1 L min
). After anaesthesia induction, the mixture was decreased to 2%.
A subcutaneous injection of carprofen (Rimadyl ® ; Pfizer, New York, NY, USA) (4 mg kg
) and enrofloxacin (Baytril ® ; Bayer, Leverkusen, Germany) (10 mg kg
) were administered and continued for the following 4 days to achieve analgesia and antimicrobial prophylaxis.
After performing local anaesthesia with articaine hydrochloride 4% with adrenaline 1:100 000 (Septocaine ® ; Septodont, Louisville, CO, USA), a para-midline incision was made to expose the rabbit calvarium. By using a trephine burr (internal diameter 5 mm), 1 standardized circular groove, 0.6 mm deep, was created in the centre of each parietal bone, as previously described. 3 By using a twist drill (0.7 mm Ø;
Medartis AG, Basel, Switzerland), 5 through-and-through cortical perforations were created to promote bleeding. One prefabricated SLA titanium dome and 1 SLActive titanium dome (Institut Straumann AG, Basel, Switzerland) with an internal diameter of 5 mm (a) and a height of 3 mm (G) were randomly placed in each circular groove, paying particular attention that their edges fitted tightly into the grooves ( Figure 1A ).
The domes presented with a 1 mm peripheral collar with four 1 mm diameter holes ( Figure 1A ). Further stabilization of the domes was achieved with gold-plated mini-screws (0.9 mm Ø and 3 mm length;
Medartis AG, ), which were screwed into the collar's holes ( Figure 1B ). The animals were randomly allocated to 3 groups according to the observation periods, which were set at 4, 7 and 14 days of healing.
After euthanasia, a para-midline incision was made to expose the rabbit calvarium, then the domes were carefully removed and the tissue underneath was harvested with an excavator and stored at −80°C.
| Protein extraction and peptide generation
Owing to the limited amount of tissue retrieved and the need to standardize the protocol for proteomic analysis, a pooling approach was adopted, which means that the tissue of the same healing period and group (SLA or SLActive) was pooled and analysed together. As a qualitative, rather than a quantitative method was employed, 3 animals per healing period were considered as an adequate number to retrieve enough samples for the analysis. ) was added to the sample and digestion took place overnight at 36°C in a humidified atmosphere. The following day, the peptide-containing solution was vacuum-dried for 1 hour, until complete pulverization. Powder was re-constituted in 100 μL of buffer A (0.1% formic acid in water). After peptide filtering using a Millex ® syringe-driven filter unit, ultra-performance liquid chromatography mass spectrometry/mass spectrometry (MS/MS) analysis followed.
| Liquid chromatography-mass spectrometry/ mass spectrometry and protein identification
Digested samples were analysed using a linear trap quadrupole (LTQ)
Orbitrap Elite mass spectrometer coupled to a Dionex 3000 HPLC system (Thermo Scientific, Rockford, IL, USA) according to a previously described protocol. 56 Briefly, peptide separation took place on 2
Thermo Scientific columns (PepMap ® RSLC, C18, 100 Å, 3 μm beadpacked 15 cm column and 2 μm bead-packed 50 cm column) connected to a Dionex Ultimate 3000 UHPLC nano-pump.
Buffer A consisted in 99.9% H 2 O and 0.1% formic acid, while
Buffer B consisted in 99% acetonitrile (ACN) and 1% H 2 O, the total elution time was 360 minutes, at a constant 300 nL min −1 flow rate.
Six microlitres of sample (equivalent to ~5 μg of peptides) were loaded on a C-18 precolumn (100 μm inner diameter ×2 cm; 100 Å, 3 μm bead-packed, Acclaim PepMap 100; Thermo Scientific) at 10 μL min −1 in 99.9% water, 0.1% formic acid. After 6 minutes of desalting, the pre-column was switched online with the analytical C-18 column (75 μm×50 cm; 100 Å, 2 μm bead-packed Acclaim PepMap RSLC; Thermo Scientific) that was equilibrated with buffer A. ply charged peptides were used. The minimum length of acceptable identified peptides was set as 6 amino acids. 57 The samples of each group and healing period were run 3 times and only the peptides identified in all 3 runs were included in the final list of identified proteins.
| Protein clustering and pathway analysis
By More specifically, with STRING the protein identifiers were first connected to their associated gene ontology (GO) terms. The enrichment analysis was then performed by comparing the abundance of specific GO terms describing "biological process," "molecular function"
and "cellular component" in our set of proteins with the background (whole genome). 58 STRING automatically returned GO terms that were significantly enriched by controlling the false discovery rate, which was corrected for multiple testing (Benjamini and Hochberg method). 59 The protein accession numbers were also entered into KEGG pathway database to perform pathway analysis.
| RESULTS
The healing was uneventful in all operated rabbits.
| Four days healing period
At 4 days, 784 common proteins (Table S1 ), 585 upregulated proteins in the SLActive group (Table S2 ) and 1190 upregulated proteins in the SLA group were detected (Table S3) .
| Common proteome to the 2 groups
The functional enrichment analysis on the common proteome resulted in a number of GO terms significantly enriched in the biological process domain (238), in the molecular function domain (66) and in the immune-inflammatory response.
Although no clear functional differences were detected between the 2 groups at 4 days of healing, a tendency towards a reduced expression of proteins involved in inflammation was suggested in the SLActive group. In fact, a higher expression of proteins belonging to the nuclear factor-kappa B, chemokine, tumour necrosis factor, cytokine-cytokine interactions and adipocytokine signalling pathways was observed under SLA domes (Table 1) ATM  BCL10  CD14  CSNK2A1  DDX58  IL1B  NFKB1  PLCG2  PRKCB  PTGS2  RIPK1  SYK   CASP3  DNM1L  IL1B  MAP2K1  MAPK1  MAPK14  MAPK3  MMP9  NFKB1  PIK3CG  PTGS2  RIPK1   ADCY3  CCL14  CXCR2  DOCK2  ELMO1  GNAI1  GSK3A  GSK3B  HCK  MAP2K1  MAPK1  MAPK3  NFKB1  PIK3CG  PLCB2  PLCB4  PREX1  PRKCB  PRKCD  PTK2  PTK2B  PXN  RAF1  RAP1A  RASGRP2  SRC  STA1  STAT3  VAV1  WAS   CXCR2  IL1B  TNFSF15   NFKB1  PCK2  PRKAA2  PRKAG1  STAT3 NF-κB, nuclear factor kappa B; TNF, tumour necrosis factor.
| Seven day healing period
At 7 days, we identified 2305 common proteins (Table S4) , 1295 upregulated proteins in the SLActive group (Table S5 ) and 627 upregulated proteins in the SLA group (Table S6) . Overall, a higher number of proteins was expressed by both groups in comparison to 4 days of healing.
| Common proteome to the 2 groups
Three hundred and one GO terms were significantly enriched in the 
| Differently expressed proteins (SLA vs SLActive)

SLActive
The functional enrichment analysis performed with STRING resulted in the positive expression of 1 GO term related to the molecular function domain (binding) in the SLActive group.
Amongst the upregulated proteins under SLActive domes, 441
(34%) were matched to 272 well-known signalling pathways, amongst which environmental information processing and metabolism were the most expressed, as they involved 125 proteins and 113 proteins, respectively.
SLA
No GO terms were significantly enriched in the SLA group.
Two hundred and twelve (34%) upregulated proteins under SLA domes were matched to 240 well-known signalling pathways, amongst which environmental information processing and metabolism were the most represented, as they involved 58 and 57 proteins,
respectively.
Similarly to what was observed on day 4, the pathways identified in the 2 groups on day 7 were overall the same and no functionally relevant differential protein expression was detected between the 2 surfaces. However, a clear tendency towards an overexpression of proteins involved in the differentiation of osteoblast precursors and in skeletal development (namely PI3K/AKT, WNT, NOTCH, AMPK and MAPK signalling pathways) ( Table 2 ), in angiogenesis (VEGF) ( Table 2) and in cell-cell interaction and adhesion (namely proteins belonging to tight junction, focal adhesion, adherens junction and Rap1 signalling pathway) was associated to the SLActive compared to the SLA group.
For instance, more than double the number of proteins of the MAPK and PI3K-AKT signalling pathways were upregulated in the SLActive group. Furthermore, key modulators of bone matrix mineralization (eg, fibroblast growth factor 23, FGF23), as well as Runx1, BMP2K, SMAD2 and FGFR1 were upregulated under hydrophilic domes at day 7 (Table 2) . Finally, an upregulation of neurogenesis and nervous system development mediators, such as ACTR1B, LHX4, PRDM1, PRDM11, SIX1, CREB1, DRD5, SNAP29 and TUBB1, together with an upregulation of NOTCH signalling pathway were associated to SLActive domes.
Remarkably, while the SLA group presented an overexpression of casein kinase 1 (CSNK1A1), which is part of the β-catenin destruction complex and therefore inactivates the WNT canonical pathway, 60 an overexpression of several proteins involved in the activation of canonical WNT (CTNBB1, CSNK2B, MAPK8), noncanonical WNT/Ca 2+ (eg, PPP3CA) and planar cell polarity (eg, DAAM2) pathways was detected in the SLActive group at 7 days of healing (Figure 2 ).
| Fourteen day healing period
At 14 days, 1339 proteins were expressed by both groups (Table S7) , 814 proteins were upregulated in the SLActive group (Table S8) and 1100 proteins were upregulated in the SLA group (Table S9) . Overall, a reduced number of proteins in comparison to the 7 day healing period was recorded on day 14.
| Common proteome to the 2 groups
Within the common proteome, 166 GO terms were significantly en- CACNA1C  CACNA1E  FGF23  FGFR1  IKBKB  MAP2K3  MAP4K4  MAPK12  MAPK8  MAPK8IP1  NF1  NR4A1  NTRK2  PPP3CA  RPS6KA1  RPS6KA3   BRCA1  CD19  CDK2  COL2A1  COL4A2  COL4A4  COL6A5  COL6A6  COL9A1  CREB1  EPHA2  FGF23  FGFR1  HSP90AA1  IKBKB  IRS1  JAK2  MLST8  MYB  NR4A1  PPP2R2A  PPP2R5B  PRKAA2  PTEN  PTK2  SYK  THBS3  THEM4   CHD8  CSNK2B  CTBP2  CTNNB1  DAAM2  INVS  MAPK8  PLCB4  PPP3CA   CTBP2  DLL3  NOTCH2  PSEN2   CREB1  IRS1  LEPR  LIPE  PFKL  PPP2R2A  PPP2R5B  PRKAA2   ROCK1  SMAD2  TFDP1  BMP2K   MAPK12  PPP3CA  PTK2  SRC modulation of specific pathways rather than in a functionally relevant differential protein expression between the 2 groups. More specifically, a higher number of proteins belonging to, JAK-STAT, HIF-1 and VEGF pathways was associated to hydrophilic titanium surfaces. Moreover, although the TGF signalling pathway was positively expressed by both groups, an upregulation of proteins belonging to the Smad-dependent BMP signalling pathway (BMPR2, SMAD4) was observed in the SLActive group, similar to that observed at earlier healing periods.
| DISCUSSION
To the best of our knowledge, this is the first study to qualitatively The dome model was adopted because it represents both a GBR and osseointegration model, due to the presence of a titanium surface. 3, 61 In fact, by applying a rigid dome/capsule, a secluded space is created, which allows the formation of bone beyond the skeletal profile and its integration with the titanium surface. 62 Although no functionally relevant differences were observed between the 2 groups at all healing periods, a different modulation of several pathways was observed between the SLA and SLActive group.
In particular, pathways involved in modulating the inflammatory response and pathways regulating osteoblast precursor differentiation and skeletogenesis accounted for the main differences in the osseous healing response associated to the 2 surfaces (Figure 4 ). Although overall the proteomes of the 2 groups were similar, on day 4, the SLA group showed a tendency towards an overexpression of pathways involved in the acute inflammatory response (such as nuclear factor-kappa B, tumour necrosis factor and chemokine signalling pathways; Table 1 ). This is in agreement with in vitro findings that showed that titanium hydrophilicity could attenuate macrophage type 1-associated proinflammatory cytokine response by the third day, probably via modulation of the proteome expressed by platelets, which are the very first cells reaching the osseous wound.
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F I G U R E 3 Schematic overview of the ECM-receptor interaction pathway. In light blue are the proteins that were expressed in both SLA and SLActive group at 14 days of healing. (Kegg output). ECM, extracellular matrix
Moving from day 4 to day 7, a more complex cellular and metabolic response was evident, thus confirming previous genomic observations 34 and suggesting that day 7 is probably the most critical period during osseous formation and osseointegration under moderately rough hydrophilic and hydrophobic titanium surfaces. GO terms specifically related to wound healing, such as response to wounding, blood vessel development, coagulation and angiogenesis were positively represented in both groups on day 7. A more complex cell interaction and cell adhesion, as well as a more advanced ECM and cytoskeleton organization were also observed. ECM is a highly dynamic structure, which plays a significant role during wound healing, as it provides mechanical and structural support to the cells, but it also regulates cell migration, differentiation and survival, mainly through integrin and proteoglycans ECM adhesion receptors. 66 On day 7, the SLActive surface seemed able to enhance further the new bone formation in comparison to the SLA surface, thus corroborating previous histology findings. 3, 20, 71 This is in consideration of the higher number of proteins belonging to pathways that display a major role in skeletogenesis, osteoprogenitor cell differentiation and F I G U R E 4 Summary of the main events taking place at the different healing periods (4, 7 and 14 days) and of the main pathways differently expressed between SLA and SLActive domes. BMP, bone morphogenetic protein; ECM, extracellular matrix; HIF, hipoxia-inducible factor; MAPK, mitogen-activated kinase; NF, nuclear factor; PI3K, phosphatidylinositol-3-kinase; TGF, transforming growth factor; TNF, tumour necrosis factor; VEGF, vascular endothelial growth factor cell adhesion that were detected in the SLActive group at this healing point (particularly Rap1, MAPK, PI3K-AKT, WNT and Notch, Table 2 ).
Conversely, on day 14, the bone formation process seemed to slow down in both groups, as documented by the overall reduced number of proteins expressed. At this later stage, a higher number of proteins modulating bone mineralization, bone remodelling, bone ECM secretion and regulation (eg, TGFBI, MMP2, MMP9, MMP13, MMP14, BMP1) was associated to both SLA and SLActive samples in comparison to earlier healing periods, thus indicating a more advanced maturation of the osseous wound and confirming previous genomic data. 34, 72, 73 Noteworthy, while the TGFβ signalling pathway was overall represented in both groups, we noticed an upregulation of proteins of the Smad-dependent BMP signalling pathway (such as BMP2K, SMAD1, SMAD2, SMAD4) in the SLActive compared to the SLA group at all healing periods. The Smad-dependent BMP pathway is known to play a major part in skeletal development and in promoting the differentiation of mesenchymal stem cells 74 and our data indicate that this might be one of the main targets of surface hydrophilicity to promote bone formation.
Previous studies have reported that neural development and neurogenesis-associated genes might play an important role during early stages of bone regeneration 34, 73, 75, 76 and our proteomic data confirmed this finding. Particularly, a significant upregulation of mediators regulating nervous system development and neurogenesis (eg, ACTR1B, LHX4, PRDM1, PRDM11, SIX1, CREB1) was associated to hydrophilic domes at day 7, as well as an upregulation of Notch and neurotrophin signalling pathways. An opposite trend was observed at 14 days of healing, thus suggesting a delayed activation on hydrophobic compared to hydrophilic surfaces.
Although this study has the merit of being the first pilot study that has investigated the molecular events accounting for the different osteogenic response associated to hydrophobic and hydrophilic titanium surfaces, it presents with some limitations. The standardization of the liquid chromatography MS/MS protocol for bone samples was particularly challenging, as to the best of our knowledge no protocol has been described in the literature before. Moreover, the limited amount of proteins retrieved and the lack of protocols for protein amplification required the application of a pooling approach. In this pilot study, we therefore provided only a qualitative (on-off) evaluation of the sequence of proteins expressed at the different healing points under SLA and SLActive surfaces, but future studies applying either label-free or isotope-labelling techniques are needed to evaluate absolute and relative differences in protein abundance at the different stages of bone formation.
The rabbit dome model was chosen because it is a wellcharacterized and reliable model of GBR and osseointegration, 3 and it allowed the placement of 2 domes per animal, thus halving the number of animals needed for the project, in respect of the "Reduction" principle in animal research. However, the rabbit proteome is still poorly characterized and several uncharacterized proteins were identified at all healing periods, which would deserve further investigation.
Early healing points (4, 7 and 14 days) were considered by this study, so we cannot draw conclusions on protein expression associated with the 2 different titanium surfaces at later healing stages. The choice of these time points was based on previous histological data showing that differences between SLA and SLActive implants were statistically significant only during the early stages, 15, 16, 18 and on genomic data showing a differential expression of angiogenesis-and osteogenesisrelated genes at days 7 and 14. 34 Future studies taking into account later healing times might be considered.
Finally, no histological analysis was performed to confirm the differences in terms of inflammatory response and bone formation between the 2 groups. However, previous studies have extensively documented the possibility to induce new bone formation and osseointegration when applying domes/capsules in the calvaria of rats and rabbits, 3, 77, 78 as well as the improved histological outcomes associated
with SLActive compared to SLA domes. 3 Despite these limitations, justified by the pilot nature of the study, we were able for the first time to provide an alternative evaluation tool (proteomic analysis) to explore the molecular mechanisms behind a combined bone formation and osseointegration model.
In comparison to previous bone healing studies (on fractures, subcritical size defects, distraction osteogenesis, etc.), the current study was able to confirm the main molecular events taking place during early stages of bone formation, but it was also able to provide a new insight on the succession of proteins and on the timing of activation of important pathways associated to inflammation, angiogenesis and bone formation. Future studies are needed to corroborate our findings and further explore the complex cascade of events occurring during bone formation in association with different surfaces. However, the proteins and pathways described in this project could already be used to help in monitoring the progression of osseous healing and the maturation stage of bone formation/osseointegration.
In the future the aim might be to develop surfaces able to target specific pathways to enhance bone regeneration, particularly in patients with severe bone loss or with systemic conditions that might jeopardize the osseous regeneration and osseointegration processes (such as osteoporosis). For instance, considering the histology and proteomic features associated to bone regeneration in healthy and osteoporotic conditions described by Calciolari et al, 56, 79 it is plausible to think that SLActive surfaces might be particularly beneficial in osteoporotic patients, owing to their ability to downregulate the inflammatory response at early stages of bone regeneration and further promote the activation of pathways regulating osteoblast precursor differentiation. Combined proteomic and histological data are therefore warranted to test the potential advantage of using hydrophilic surfaces in systemically compromised conditions.
